BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/22/2021 8:09:41 AM | Browse: 599 | Download: 1361
 |
Received |
|
2021-05-19 19:19 |
|
Peer-Review Started |
|
2021-05-19 19:23 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-06-04 03:47 |
|
Revised |
|
2021-06-04 18:13 |
|
Second Decision |
|
2021-08-16 03:31 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2021-08-16 09:17 |
|
Articles in Press |
|
2021-08-16 09:17 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2021-09-17 01:21 |
|
Publish the Manuscript Online |
|
2021-09-22 08:09 |
| ISSN |
1948-5182 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Minireviews |
| Article Title |
Probiotics in hepatology: An update
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Roman Maslennikov, Vladimir Ivashkin, Irina Efremova, Elena Poluektova and Elena Shirokova |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Roman Maslennikov, MD, PhD, Professor, Department of Internal Medicine, Gastroenterology and Hepatology, Sechenov University, Pogodinsckays str. 1-1, Moscow 119435, Russia. mmmm00@yandex.ru |
| Key Words |
Gut-liver axis; Pathogenesis; Gut dysbiosis; Gut microbiota; Gut microbiome; Liver disease; Probiotics; Hepatic encephalopathy; Cirrhosis; Metabolic associated fatty liver disease; Alcoholic liver disease; Primary sclerosing cholangitis |
| Core Tip |
Probiotics are useful for hepatic encephalopathy, but their effects on other symptoms and syndromes of cirrhosis are poorly studied. Their effectiveness in the treatment of metaboliс associated fatty liver disease has been shown both in experimental models and in clinical trials, but their effect on the prognosis of this disease has not been described. The beneficial effects of probiotics in alcoholic liver disease have been shown in many experimental studies, but there are very few clinical trials to support these findings. The effects of probiotics on the course of other liver diseases are either poorly studied or not studied at all. |
| Publish Date |
2021-09-22 08:09 |
| Citation |
Maslennikov R, Ivashkin V, Efremova I, Poluektova E, Shirokova E. Probiotics in hepatology: An update. World J Hepatol 2021; 13(9): 1154-1166 |
| URL |
https://www.wjgnet.com/1948-5182/full/v13/i9/1154.htm |
| DOI |
https://dx.doi.org/10.4254/wjh.v13.i9.1154 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
